European Union Drug Pricing Proposal for the Pandemic Treaty Generates Pushback

Professor Brook Baker comments on the pharmaceutical industry’s arbitrary approach to provide medicines to poor and middle-income countries, because it can lead to higher prices and fails to address calls for technology transfers. “What people have been asking for is technology sharing and licensing rights to expand manufacturing capacity” said Baker in STAT News, “This (proposal) is pretty much leaving company intellectual property alone and relying on voluntary measures.”